Approved labelLeuprolide acetate daily-injection kit prescribing information for advanced prostate cancer
PopulationAdults covered by the approved daily leuprolide indication
Dose1 mg (0.2 mL)
RouteSubcutaneous injection with periodic site rotation
FrequencyOnce daily
DurationLong-term use within the approved indication
PreparationReady-to-use solution in a 2.8 mL multiple-dose vial; no reconstitution. Inspect for discoloration or particles before use.